VEEV
Veeva Systems Inc-Class A
NYSE · Health Care
$183.65
-0.20 (-0.11%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.74B | 2.40B | 15.85B | 14.30B | 13.12B |
| Net Income | 711.62M | 561.51M | 1.03B | 1.23B | 945.93M |
| EPS | — | — | — | — | — |
| Profit Margin | 26.0% | 24.7% | 6.5% | 8.6% | 7.2% |
| Rev Growth | +14.1% | +14.1% | +23.7% | +0.9% | -8.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 15.97B | 12.79B | 12.08B |
| Total Equity | — | — | 10.05B | 10.66B | 11.53B |
| D/E Ratio | — | — | 1.59 | 1.20 | 1.05 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 725.80M | 604.51M | 2.09B | 1.77B | 1.57B |
| Free Cash Flow | — | — | 1.09B | 978.68M | 1.27B |